23 May 2013
Keywords: gsk, agrees, buy, sirtris, 720m, gain, foothold
Article | 28 April 2008
UK drug major GlaxoSmithKline has agreed to acquire Sirtris Pharmaceuticals for $720.0 million, bolstering its pipeline with the US
biotechnology firm's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 April 2008
22 May 2013
© 2013 thepharmaletter.com